Of all sphingolipids, the relative levels of dihydroceramide were increased the most in patient plasma samples, suggesting that DEGS1 activity becomes limiting in the presence of enhanced SPT activity and that dihydroceramide accumulation contributes to juvenile ALS. This evidence concerns the gene AGXT and amyotrophic lateral sclerosis.